Pozo-Rosich P, Lopez JAG, Lisewski P, Aslan AN, et al. A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications. Cephalalgia 2025;45:3331024251391378.
PMID: 41255098